Mon Parcours de Vie: information and support booklets for localized breast cancer
"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.
This pilot will test whether giving French-language Mon Parcours de Vie information booklets to women with localized breast cancer improves their understanding, support, and experience during medical treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Institut de Cancérologie de Lorraine Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Vandœuvre-lès-Nancy) |
| Trial ID | NCT07165756 on ClinicalTrials.gov |
What this trial studies
This observational pilot enrolls women with localized invasive breast cancer receiving local and systemic treatment to examine the impact of caregiver-authored information booklets produced by Mon Parcours de Vie. Participants receive access to printed and online booklets covering diagnosis, treatments, well-being and support, and outcomes such as patient-reported understanding, satisfaction, and psychosocial support are collected. The design is non-interventional and relies on questionnaires and routine clinical follow-up, with inclusion criteria requiring French language fluency and WHO performance status ≤1. Findings will inform whether these materials should be more broadly distributed in French cancer centers.
Who should consider this trial
Good fit: Women with localized invasive breast cancer about to receive local and medical treatment (chemotherapy ± immunotherapy or anti-HER2 therapy), who speak French, have WHO performance status ≤1, can consent and are treated at the participating center, are ideal candidates.
Not a fit: Patients with metastatic disease, a prior other cancer, inability to read or speak French, inability to consent, or who are under legal guardianship are unlikely to benefit from this pilot.
Why it matters
Potential benefit: If successful, patients could gain clearer information, greater emotional support, and improved confidence during treatment decisions and care.
How similar studies have performed: Previous studies of structured patient education materials have shown modest gains in knowledge and satisfaction, but this specific caregiver-authored booklet format is relatively novel and not widely tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with localized breast cancer consulting for medical treatment (chemotherapy+/- immunotherapy+/anti-HER2 targeted therapy) * Diagnosis of invasive breast cancer for which there is an indication for local and medical treatment. * WHO ≤ 1 * Patient has understood, signed and dated the consent form * Patient affiliated to the social security system Exclusion Criteria: * Patient with metastatic breast cancer * History of other cancer * Patient unable to read or speak French * Persons deprived of liberty or under guardianship (including curatorship).
Where this trial is running
Vandœuvre-lès-Nancy
- Institut de Cancérologie de Lorraine — Vandœuvre-lès-Nancy, France (Recruiting)
Study contacts
- Study coordinator: Jean-Louis MERLIN
- Email: jl.merlin@nancy.unicancer.fr
- Phone: +33 3 83 59 84 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.